12:00 AM
 | 
May 06, 2013
 |  BC Week In Review  |  Financial News  |  Other Financial News

Symphogen financial update

Symphogen secured €41 million ($53.4 million) in an extension of a tranched €100 million ($132.9 million) series E round, bringing the total...

Read the full 90 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >